# Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight Loss

> **NCT02941445** · PHASE4 · COMPLETED · sponsor: **University Medical Centre Ljubljana** · enrollment: 24 (actual)

## Conditions studied

- Polycystic Ovary Syndrome
- Body Weight

## Interventions

- **DRUG:** sitagliptin and metformin
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT02941445
- **Lead sponsor:** University Medical Centre Ljubljana
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2016-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02941445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02941445, "Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight Loss". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02941445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*